Medical history, lifestyle, family history, and occupational risk factors for marginal zone lymphoma: The interLymph non-Hodgkin lymphoma subtypes project

Journal of the National Cancer Institute - Monographs

Volumn , Issue 48, 2014, Pages 52-65

  Bracci, Paige M ^a   Benavente, Yolanda ^b,c   Turner, Jennifer J ^d,e   Paltiel, Ora ^f   Slager, Susan L ^g   Vajdic, Claire M ^h   Norman, Aaron D ^g   Cerhan, James R ^g   Chiu, Brian C H ^j   Becker, Nikolaus ⁱ   Cocco, Pierluigi ^k   Dogan, Ahmet ^l   Nieters, Alexandra ^m   Holly, Elizabeth A ^a   Kane, Eleanor V ⁿ   Smedby, Karin E ^o   Maynadié, Marc ^p,q   Spinelli, John J ^r   Roman, Eve ⁿ   Glimelius, Bengt ^d   Wang, Sophia S ^s,t,u   Sampson, Joshua N ^v   Morton, Lindsay M ^v   de Sanjosé, Silvia ^b,c   more..

^a UNIVERSITY OF CALIFORNIA   (United States)

^b BELLVITGE BIOMEDICAL RESEARCH INSTITUTE IDIBELL   (Spain)

^c CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^d Department of Histopathology Douglass Hanly Moir Pathology ^*

^e MACQUARIE UNIVERSITY   (Australia)

^f HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^g Mayo Clinic   (United States)

^h UNIVERSITY OF NEW SOUTH WALES   (Australia)

ⁱ GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^j UNIVERSITY OF CHICAGO   (United States)

^k UNIVERSITY OF CAGLIARI   (Italy)

^l MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^m UNIVERSITY OF FREIBURG   (Germany)

ⁿ UNIVERSITY OF YORK   (United Kingdom)

^o KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^p DIJON UNIVERSITY HOSPITAL   (France)

^q UNIVERSITÉ DE BOURGOGNE   (France)

^r BRITISH COLUMBIA CANCER AGENCY   (Canada)

^s UPPSALA UNIVERSITY   (Sweden)

^t KAROLINSKA INSTITUTE   (Sweden)

^u CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^v NATIONAL CANCER INSTITUTE   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; AUSTRALIA; CASE CONTROL STUDY; COMORBIDITY; ETHNOLOGY; EUROPE; FEMALE; HUMAN; LIFESTYLE; LYMPHOMA, B-CELL, MARGINAL ZONE; MALE; META ANALYSIS; MIDDLE AGED; NORTH AMERICA; OCCUPATIONAL EXPOSURE; ODDS RATIO; RISK FACTOR; VERY ELDERLY; YOUNG ADULT; ALCOHOL CONSUMPTION; ARTICLE; ASTHMA; ATOPY; B LYMPHOCYTE; CANCER RISK; CONTROLLED STUDY; FAMILY HISTORY; HEPATITIS C VIRUS; MAJOR CLINICAL STUDY; MARGINAL ZONE LYMPHOMA; MEDICAL HISTORY; OCCUPATIONAL HAZARD; PEPTIC ULCER; RISK REDUCTION; SELF REPORT; TEACHER; WINE;

ADULT; AGED; AGED, 80 AND OVER; AUSTRALIA; CASE-CONTROL STUDIES; COMORBIDITY; EUROPE; FEMALE; HUMANS; LIFE STYLE; LYMPHOMA, B-CELL, MARGINAL ZONE; MALE; MIDDLE AGED; NORTH AMERICA; OCCUPATIONAL EXPOSURE; ODDS RATIO; RISK FACTORS; YOUNG ADULT;

HAIR DYE;

EID: 84906842489     PISSN: 10526773     EISSN: 17456614     Source Type: Book Series    
DOI: 10.1093/jncimonographs/lgu011     Document Type: Article

References (40)

1. Roman E, Smith AG. Epidemiology of lymphomas. Histopathology. 2011;58(1):4-14.
2. Smith A, Howell D, Patmore R, Jack A, Roman E. Incidence of haematological malignancy by sub-type: a report from the Haematological Malignancy Research Network. Br J Cancer. 2011;105(11):1684-1692.
3. Jaffe ES, Harris NL, Stein H, Vardiman JW, eds. World Health Organization Classification of Tumours of Haematopoietic and Lymphoid Tissues. 3rd ed. Lyon, France: IARC Press; 2001.
4. Swerdlow SH, Campo E, Harris NL, et al. eds. World Health Organization Classification of Tumours of Haematopoietic and Lymphoid Tissues. 4th ed. Lyon, France: IARC Press; 2008.
5. Harris NL, Jaffe ES, Stein H, et al. A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood. 1994;84(5):1361-1392.
6. Khalil MO, Morton LM, Devesa SS, et al. Incidence of marginal zone lymphoma in the United States, 2001-2009 with a focus on primary anatomic site. Br J Haematol. 2014;165(1):67-77.
7. Ferreri AJ, Zucca E. Marginal-zone lymphoma. Crit Rev Oncol Hematol. 2007;63(3):245-256.
8. Hjalgrim H, Engels EA. Infectious aetiology of Hodgkin and non-Hodgkin lymphomas: a review of the epidemiological evidence. J Intern Med. 2008;264(6):537-548.
9. Abruzzo LV, Sargent RL. Marginal zone B-cell lymphoma. In: Dunphy CH, ed. Pathology of Hematolymphoid Diseases. New York, NY: Springer; 2010:221-232.
10. Ferreri AJ, Govi S, Ponzoni M. Marginal zone lymphomas and infectious agents. Semin Cancer Biol. 2013;23(6):431-440.
11. Thieblemont C, Davi F, Noguera ME, Brière J. Non-MALT marginal zone lymphoma. Curr Opin Hematol. 2011;18(4):273-279.
12. Bates I, Bedu-Addo G, Jarrett RF, et al. B-lymphotropic viruses in a novel tropical splenic lymphoma. Br J Haematol. 2001;112(1):161-166.
13. Arcaini L, Paulli M, Boveri E, et al. Splenic and nodal marginal zone lymphomas are indolent disorders at high hepatitis C virus seroprevalence with distinct presenting features but similar morphologic and phenotypic profiles. Cancer. 2004;100(1):107-115.
14. Morton LM, Turner JJ, Cerhan JR, et al. Proposed classification of lymphoid neoplasms for epidemiologic research from the Pathology Working Group of the International Lymphoma Epidemiology Consortium (InterLymph). Blood. 2007;110(2):695-708.
15. Turner JJ, Morton LM, Linet MS, et al. InterLymph hierarchical classification of lymphoid neoplasms for epidemiologic research based on the WHO classification (2008): update and future directions. Blood. 2010;116(20):e90-e98.
16. Edge SB, Byrd DR, Compton CC, et al., eds. AJCC Cancer Staging Manual. 7th ed. New York, NY: Springer; 2010.
17. Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21(11):1539-1558.
18. Wang SS, Slager SL, Brennan P, et al. Family history of hematopoietic malignancies and risk of non-Hodgkin lymphoma (NHL): a pooled analysis of 10 211 cases and 11 905 controls from the International Lymphoma Epidemiology Consortium (InterLymph). Blood. 2007;109(8):3479-3488.
19. Ekström Smedby K, Vajdic CM, Falster M, et al. Autoimmune disorders and risk of non-Hodgkin lymphoma subtypes: a pooled analysis within the InterLymph Consortium. Blood. 2008;111(8):4029-4038.
20. Vajdic CM, Falster MO, de Sanjosé S, et al. Atopic disease and risk of non-Hodgkin lymphoma: an InterLymph pooled analysis. Cancer Res. 2009;69(16):6482-6489.
21. Zhang Y, de Sanjosé S, Bracci PM, et al. Personal use of hair dye and the risk of certain subtypes of non-Hodgkin lymphoma. Am J Epidemiol. 2008;167(11):1321-1331.
22. de Sanjosé S, Benavente Y, Vajdic CM, et al. Hepatitis C and non-Hodgkin lymphoma among 4784 cases and 6269 controls from the International Lymphoma Epidemiology Consortium. Clin Gastroenterol Hepatol. 2008;6(4):451-458.
23. Kricker A, Armstrong BK, Hughes AM, et al.; Interlymph Consortium. Personal sun exposure and risk of non Hodgkin lymphoma: a pooled analysis from the Interlymph Consortium. Int J Cancer. 2008;122(1):144-154.
24. Czene K, Adami HO, Chang ET. Sex- and kindred-specific familial risk of non-Hodgkin's lymphoma. Cancer Epidemiol Biomarkers Prev. 2007;16(11):2496-2499.
25. Chang ET, Smedby KE, Hjalgrim H, Glimelius B, Adami HO. Reliability of self-reported family history of cancer in a large case-control study of lymphoma. J Natl Cancer Inst. 2006;98(1):61-68.
26. Tramacere I, Pelucchi C, Bonifazi M, et al. Alcohol drinking and non- Hodgkin lymphoma risk: a systematic review and a meta-analysis. Ann Oncol. 2012;23(11):2791-2798.
27. Anderson LA, Gadalla S, Morton LM, et al. Population-based study of autoimmune conditions and the risk of specific lymphoid malignancies. Int J Cancer. 2009;125(2):398-405.
28. Goldin LR, Landgren O. Autoimmunity and lymphomagenesis. Int J Cancer. 2009;124(7):1497-1502.
29. Mavragani CP, Moutsopoulos HM. Sjögren's syndrome. Annu Rev Pathol. 2014;9:273-285.
30. Routsias JG, Goules JD, Charalampakis G, Tzima S, Papageorgiou A, Voulgarelis M. Malignant lymphoma in primary Sjögren's syndrome: an update on the pathogenesis and treatment. Semin Arthritis Rheum. 2013;43(2):178-186.
31. Peveling-Oberhag J, Arcaini L, Hansmann ML, Zeuzem S. Hepatitis C-associated B-cell non-Hodgkin lymphomas. Epidemiology, molecular signature and clinical management. J Hepatol. 2013;59(1):169-177.
32. Strachan DP. Hay fever, hygiene, and household size. BMJ. 1989;299(6710):1259-1260.
33. Ellison-Loschmann L, Benavente Y, Douwes J, et al. Immunoglobulin E levels and risk of lymphoma in a case-control study in Spain. Cancer Epidemiol Biomarkers Prev. 2007;16(7):1492-1498.
34. Amin K, Lúdvíksdóttir D, Janson C, et al. Inflammation and structural changes in the airways of patients with atopic and nonatopic asthma. BHR Group. Am J Respir Crit Care Med. 2000;162(6):2295-2301.
35. Pillai P, Corrigan CJ, Ying S. Airway epithelium in atopic and nonatopic asthma: similarities and differences. ISRN Allergy. 2011;2011:195846.
36. Cogliano VJ, Baan R, Straif K, et al. Preventable exposures associated with human cancers. J Natl Cancer Inst. 2011;103(24):1827-1839.
37. Mirer F. Updated epidemiology of workers exposed to metalworking fluids provides sufficient evidence for carcinogenicity. Appl Occup Environ Hyg. 2003;18(11):902-912.
38. Dolcetti R, Serraino D, Dognini G, et al. Exposure to animals and increased risk of marginal zone B-cell lymphomas of the ocular adnexae. Br J Cancer. 2012;106(5):966-969.
39. Chia SE, Wong KY, Tai BC. Occupation and risk of non-Hodgkin's lymphoma in Singapore. Occup Med (Lond). 2012;62(1):29-33.
40. van den Brand M, van Krieken JH. Recognizing nodal marginal zone lymphoma: recent advances and pitfalls. A systematic review. Haematologica. 2013;98(7):1003-1013.